1-7 of 7
Ashraf Badros
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase Ib/II Study of Oprozomib in Patients with Advanced Multiple Myeloma and Waldenström Macroglobulinemia

Irene M. Ghobrial, Ravi Vij, David Siegel, Ashraf Badros, Jonathan Kaufman, Noopur Raje, Andrzej Jakubowiak, Michael R. Savona, Mihaela Obreja, Jesus G. Berdeja
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (16): 4907–4916.
https://doi.org/10.1158/1078-0432.CCR-18-3728
Published: 15 August 2019
View article titled, A Phase Ib/II Study of Oprozomib in Patients with Advanced Multiple Myeloma and Waldenström Macroglobulinemia
Open the PDF for A Phase Ib/II Study of Oprozomib in Patients with Advanced Multiple Myeloma and Waldenström Macroglobulinemia in another window
Includes: Supplementary data
Journal Articles

Bone Marker–Directed Dosing of Zoledronic Acid for the Prevention of Skeletal Complications in Patients with Multiple Myeloma: Results of the Z-MARK Study

Noopur Raje, Robert Vescio, Charles W. Montgomery, Ashraf Badros, Nikhil Munshi, Richard Orlowski, Joseph T. Hadala, Ghulam Warsi, Eliza Argonza-Aviles, Solveig G. Ericson, Kenneth C. Anderson
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (6): 1378–1384.
https://doi.org/10.1158/1078-0432.CCR-15-1864
Published: 14 March 2016
View article titled, Bone Marker–Directed Dosing of Zoledronic Acid for the Prevention of Skeletal Complications in Patients with Multiple Myeloma: Results of the Z-MARK Study
Open the PDF for Bone Marker–Directed Dosing of Zoledronic Acid for the Prevention of Skeletal Complications in Patients with Multiple Myeloma: Results of the Z-MARK Study in another window
Journal Articles

A Phase I Dose-Escalation Study of Antibody BI-505 in Relapsed/Refractory Multiple Myeloma

Markus Hansson, Peter Gimsing, Ashraf Badros, Titti Martinsson Niskanen, Hareth Nahi, Fritz Offner, Morten Salomo, Elisabeth Sonesson, Morten Mau-Sorensen, Yvonne Stenberg, Annika Sundberg, Ingrid Teige, Jan Van Droogenbroeck, Stina Wichert, Maurizio Zangari, Björn Frendeus, Magnus Korsgren, Martine Poelman, Guido Tricot
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2015) 21 (12): 2730–2736.
https://doi.org/10.1158/1078-0432.CCR-14-3090
Published: 14 June 2015
View article titled, A Phase I Dose-Escalation Study of Antibody BI-505 in Relapsed/Refractory Multiple Myeloma
Open the PDF for A Phase I Dose-Escalation Study of Antibody BI-505 in Relapsed/Refractory Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T Cells

Aaron P. Rapoport, Nicole A. Aqui, Edward A. Stadtmauer, Dan T. Vogl, Yin Yan Xu, Michael Kalos, Ling Cai, Hong-Bin Fang, Brendan M. Weiss, Ashraf Badros, Saul Yanovich, Gorgun Akpek, Patricia Tsao, Alan Cross, Dean Mann, Sunita Philip, Naseem Kerr, Andrea Brennan, Zhaohui Zheng, Kathleen Ruehle, Todd Milliron, Scott E. Strome, Andres M. Salazar, Bruce L. Levine, Carl H. June
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2014) 20 (5): 1355–1365.
https://doi.org/10.1158/1078-0432.CCR-13-2817
Published: 02 March 2014
View article titled, Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T Cells
Open the PDF for Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T Cells in another window
Includes: Supplementary data
Journal Articles

Phase I Study of Vorinostat in Combination with Bortezomib for Relapsed and Refractory Multiple Myeloma

Ashraf Badros, Angelika M. Burger, Sunita Philip, Ruben Niesvizky, Sarah S. Kolla, Olga Goloubeva, Carolynn Harris, James Zwiebel, John J. Wright, Igor Espinoza-Delgado, Maria R. Baer, Julianne L. Holleran, Merrill J. Egorin, Steven Grant
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (16): 5250–5257.
https://doi.org/10.1158/1078-0432.CCR-08-2850
Published: 12 August 2009
View article titled, Phase I Study of Vorinostat in Combination with Bortezomib for Relapsed and Refractory Multiple Myeloma
Open the PDF for Phase I Study of Vorinostat in Combination with Bortezomib for Relapsed and Refractory Multiple Myeloma in another window
Journal Articles

Multicenter Clinical Trial of Bortezomib in Relapsed/Refractory Waldenstrom's Macroglobulinemia: Results of WMCTG Trial 03-248

Steven P. Treon, Zachary R. Hunter, Jeffrey Matous, Robin M. Joyce, Brian Mannion, Ranjana Advani, David Cook, Joseph Songer, John Hill, Bruce R. Kaden, David Sharon, Ronald Steiss, Xavier Leleu, Andrew R. Branagan, Ashraf Badros
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (11): 3320–3325.
https://doi.org/10.1158/1078-0432.CCR-06-2511
Published: 01 June 2007
View article titled, Multicenter Clinical Trial of Bortezomib in Relapsed/Refractory Waldenstrom's Macroglobulinemia: Results of WMCTG Trial 03-248
Open the PDF for Multicenter Clinical Trial of Bortezomib in Relapsed/Refractory Waldenstrom's Macroglobulinemia: Results of WMCTG Trial 03-248 in another window
Journal Articles

Phase I Clinical Trial of the Inosine Monophosphate Dehydrogenase Inhibitor Mycophenolate Mofetil (Cellcept) in Advanced Multiple Myeloma Patients

Naoko Takebe, Xiangfei Cheng, Suhlan Wu, Kenneth Bauer, Olga G. Goloubeva, Robert G. Fenton, Meyer Heyman, Aaron P. Rapoport, Ashraf Badros, John Shaughnessy, Douglas Ross, Barry Meisenberg, Guido Tricot
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (24): 8301–8308.
https://doi.org/10.1158/1078-0432.CCR-04-0747
Published: 28 December 2004
View article titled, Phase I Clinical Trial of the Inosine Monophosphate Dehydrogenase Inhibitor Mycophenolate Mofetil (Cellcept) in Advanced Multiple Myeloma Patients
Open the PDF for Phase I Clinical Trial of the Inosine Monophosphate Dehydrogenase Inhibitor Mycophenolate Mofetil (Cellcept) in Advanced Multiple Myeloma Patients in another window